HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Shedding light on immunotherapy for cancer.

AuthorsSteven A Rosenberg (Affiliation: National Cancer Institute, Bethesda, Md, USA.)
JournalThe New England journal of medicine (N Engl J Med) Vol. 350 Issue 14 Pg. 1461-3 (Apr 1 2004) ISSN: 1533-4406 [Electronic] United States
PMID15070799 (Publication Type: Journal Article, Review)
Chemical References
  • Cancer Vaccines
  • Membrane Proteins
  • Tnfsf14 protein, mouse
  • Tumor Necrosis Factor Ligand Superfamily Member 14
  • Tumor Necrosis Factor-alpha
Topics
  • Animals
  • Cancer Vaccines
  • Disease Models, Animal
  • Immunotherapy (methods)
  • Lymphocytes, Tumor-Infiltrating
  • Membrane Proteins (genetics, immunology)
  • Mice
  • Neoplasms (immunology, therapy)
  • T-Lymphocytes (immunology)
  • Tumor Necrosis Factor Ligand Superfamily Member 14
  • Tumor Necrosis Factor-alpha (genetics, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD